Chest bump.

Where does radiation stand in the era of atezolizumab for extensive-stage small cell lung cancer? This helpful review takes a deep dive and comes away putting all its money on chest consolidation. With immune checkpoint inhibition on board, a growing number of responders will likely see a benefit with the proven-safe and possibly-synergistic addition of radiation to residual thoracic disease. On the other hand, with paces of brain mets slowing, prophylactic brain radiation seems less helpful than ever. | Nesbit, Transl Lung Cancer Res 2019